Works matching AU Sridhar, Srikala S.

Results: 72
    1

    On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 275, doi. 10.1007/s40487-025-00334-6
    By:
    • Szabados, Bernadett E.;
    • Guerrero-Ramos, Félix;
    • Grande, Enrique;
    • Grivas, Petros;
    • Grünwald, Viktor;
    • Miguel, Marta Carpintero;
    • Hussain, Syed A.;
    • Kulkarni, Girish S.;
    • Wilson, Ana Lisa;
    • Shore, Neal D.;
    • Sridhar, Srikala S.;
    • Hoyt, Mary;
    • Strumeier, Samantha;
    • Sutton, Jennifer;
    • Brinkmann, Julia;
    • Teresi, Rosemary E.;
    • Todenhöfer, Tilman
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.

    Published in:
    BJU International, 2021, v. 128, n. 1, p. 79, doi. 10.1111/bju.15289
    By:
    • Soria, Francesco;
    • Black, Peter C.;
    • Fairey, Adrian S.;
    • Cookson, Michael S.;
    • Yu, Evan Y.;
    • Kassouf, Wassim;
    • Dall'Era, Marc A.;
    • Sridhar, Srikala S.;
    • McGrath, John S.;
    • Wright, Jonathan L.;
    • Thorpe, Andrew C.;
    • Morgan, Todd M.;
    • Daneshmand, Siamak;
    • Holzbeierlein, Jeff M.;
    • Bivalacqua, Trinity J.;
    • North, Scott;
    • Barocas, Daniel A.;
    • Lotan, Yair;
    • Grivas, Petros;
    • Stephenson, Andrew J.
    Publication type:
    Article
    12

    Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.

    Published in:
    BJU International, 2021, v. 127, n. 5, p. 528, doi. 10.1111/bju.15253
    By:
    • D'Andrea, David;
    • Matin, Surena;
    • Black, Peter C.;
    • Petros, Firas G.;
    • Zargar, Homayoun;
    • Dinney, Colin P.;
    • Cookson, Michael S.;
    • Kassouf, Wassim;
    • Dall'Era, Marc A.;
    • McGrath, John S.;
    • Wright, Jonathan L.;
    • Thorpe, Andrew C.;
    • Morgan, Todd M.;
    • Holzbeierlein, Jeffrey M.;
    • Bivalacqua, Trinity J.;
    • Sridhar, Srikala S.;
    • North, Scott;
    • Barocas, Daniel A.;
    • Lotan, Yair;
    • Stephenson, Andrew J.
    Publication type:
    Article
    13

    A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.

    Published in:
    BJU International, 2014, v. 113, n. 5b, p. E137, doi. 10.1111/bju.12564
    By:
    • Pond, Gregory R.;
    • Agarwal, Neeraj;
    • Bellmunt, Joaquim;
    • Choueiri, Toni K.;
    • Qu, Angela;
    • Fougeray, Ronan;
    • Vaughn, David;
    • James, Nicholas D.;
    • Salhi, Yacine;
    • Albers, Peter;
    • Niegisch, Günter;
    • Galsky, Matthew D.;
    • Wong, Yu‐Ning;
    • Ko, Yoo‐Joung;
    • Stadler, Walter M.;
    • O'Donnell, Peter H.;
    • Sridhar, Srikala S.;
    • Vogelzang, Nicholas J.;
    • Necchi, Andrea;
    • Di Lorenzo, Giuseppe
    Publication type:
    Article
    14
    15
    16

    2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.

    Published in:
    Canadian Urological Association Journal, 2025, v. 19, n. 1, p. E1, doi. 10.5489/cuaj.9096
    By:
    • Kulkarni, Girish S.;
    • Black, Peter C.;
    • Sridhar, Srikala S.;
    • Zlotta, Alexandre R.;
    • Shayegan, Bobby;
    • Rendon, Ricardo A.;
    • Chung, Peter;
    • van der Kwast, Theodorus;
    • Alimohamed, Nimira;
    • Fradet, Yves;
    • Kokorovic, Andrea;
    • Cury, Fabio L.;
    • Kassouf, Wassim
    Publication type:
    Article
    17
    18

    The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.

    Published in:
    Canadian Urological Association Journal, 2023, v. 17, n. 10, p. 301, doi. 10.5489/cuaj.8570
    By:
    • Ho, Matthew D.;
    • Black, Anna J.;
    • Zargar, Homayoun;
    • Fairey, Adrian S.;
    • Mertens, Laura S.;
    • Dinney, Colin P.;
    • Mir, Maria C.;
    • Krabbe, Laura-Maria;
    • Cookson, Michael S.;
    • Jacobsen, Niels-Erik;
    • Montgomery, Jeffrey S.;
    • Yu, Evan Y.;
    • Xylinas, Evanguelos;
    • Kassouf, Wassim;
    • Dall‘Era, Marc A.;
    • Vasdev, Nikhil;
    • Sridhar, Srikala S.;
    • McGrath, John S.;
    • Aning, Jonathan;
    • Holzbeierlein, Jeff M.
    Publication type:
    Article
    19
    20
    21

    2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

    Published in:
    Canadian Urological Association Journal, 2022, v. 16, n. 11, p. E506, doi. 10.5489/cuaj.8161
    By:
    • Saad, Fred;
    • Aprikian, Armen;
    • Finelli, Antonio;
    • Fleshner, Neil E.;
    • Gleave, Martin;
    • Kapoor, Anil;
    • Niazi, Tamim;
    • North, Scott A.;
    • Pouliot, Fréderic;
    • Rendon, Ricardo A.;
    • Shayegan, Bobby;
    • Sridhar, Srikala S.;
    • So, Alan I.;
    • Usmani, Nawaid;
    • Vigneault, Eric;
    • Chi, Kim N.
    Publication type:
    Article
    22
    23
    24
    25
    26

    Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscleinvasive bladder cancer.

    Published in:
    Canadian Urological Association Journal, 2020, v. 14, n. 12, p. 404, doi. 10.5489/cuaj.6459
    By:
    • Ajib, Khaled;
    • Tjong, Michael C.;
    • Guan Hee Tan;
    • Nason, Gregory J.;
    • Berjaoui, Mohamad Baker;
    • Erlich, Annette;
    • Maganti, Manjula;
    • Sridhar, Srikala S.;
    • Fleshner, Neil E.;
    • Zlotta, Alexandre R.;
    • Catton, Charles;
    • Berlin, Alejandro;
    • Chung, Peter;
    • Kulkarni, Girish S.
    Publication type:
    Article
    27

    Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.

    Published in:
    Canadian Urological Association Journal, 2020, v. 14, n. 5, p. E154, doi. 10.5489/cuaj.6595
    By:
    • Lalani, Aly-Khan A.;
    • Chi, Kim N.;
    • Heng, Daniel Y. C.;
    • Kollmannsberger, Christian K.;
    • Sridhar, Srikala S.;
    • Blais, Normand;
    • Canil, Christina;
    • Czaykowski, Piotr;
    • Hotte, Sebastien J.;
    • Iqbal, Nayyer;
    • Soulières, Denis;
    • Bossé, Dominick;
    • Alimohamed, Nimira S.;
    • Basappa, Naveen S.;
    • Mukherjee, Som D.;
    • Winquist, Eric;
    • Wood, Lori A.;
    • North, Scott A.
    Publication type:
    Article
    28
    29
    30

    Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.

    Published in:
    Canadian Urological Association Journal, 2019, v. 13, n. 10, p. 318, doi. 10.5489/cuaj.6015
    By:
    • Warren, Mark;
    • Kolinsky, Michael;
    • Canil, Christina M.;
    • Czaykowski, Piotr;
    • Sridhar, Srikala S.;
    • Black, Peter C.;
    • Booth, Christopher M.;
    • Kassouf, Wassim;
    • Eapen, Libni;
    • Mukherjee, Som D.;
    • Biais, Normand;
    • Eigl, Bernhard J.;
    • Winquist, Eric;
    • Basappa, Naveen S.;
    • North, Scott A.
    Publication type:
    Article
    31

    2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

    Published in:
    Canadian Urological Association Journal, 2019, v. 13, n. 10, p. 307, doi. 10.5489/cuaj.6136
    By:
    • Saad, Fred;
    • Aprikian, Armen;
    • Finelli, Antonio;
    • Fleshner, Neil E.;
    • Gleave, Martin;
    • Kapoor, Anil;
    • Niazi, Tamim;
    • North, Scott A.;
    • Pouliot, Frederic;
    • Rendon, Ricardo A.;
    • Shayegan, Bobby;
    • Sridhar, Srikala S.;
    • So, Alan;
    • Usmani, Nawaid;
    • Vigneault, Eric;
    • Chi, Kim N.
    Publication type:
    Article
    32

    Canadian Urological Association guideline: Muscle-invasive bladder cancer.

    Published in:
    Canadian Urological Association Journal, 2019, v. 13, n. 8, p. 230, doi. 10.5489/cuaj.5902
    By:
    • Kulkarni, Girish S.;
    • Black, Peter C.;
    • Sridhar, Srikala S.;
    • Kapoor, Anil;
    • Zlotta, Alexandre R.;
    • Shayegan, Bobby;
    • Rendon, Ricardo A.;
    • Chung, Peter;
    • van der Kwast, Theodorus;
    • Alimohamed, Nimira;
    • Fradet, Yves;
    • Kassouf, Wassim
    Publication type:
    Article
    33

    Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.

    Published in:
    Canadian Urological Association Journal, 2018, v. 12, n. 7, p. E281, doi. 10.5489/cuaj.5246
    By:
    • Kassouf, Wassim;
    • Aprikian, Armen;
    • Saad, Fred;
    • Breau, Rodney H.;
    • Kulkarni, Girish;
    • Guttman, David M.;
    • Bagshaw, Ken;
    • Izawa, Jonathan;
    • Eapen, Libni;
    • Fairey, Adrian;
    • So, Alan;
    • North, Scott;
    • Rendon, Ricardo;
    • Sridhar, Srikala S.;
    • Brimo, Fadi;
    • Chung, Peter;
    • Drachenberg, Darrel;
    • Fradet, Yves;
    • Jacobsen, Niels;
    • Morash, Chris
    Publication type:
    Article
    34
    35

    The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis.

    Published in:
    Canadian Urological Association Journal, 2016, v. 10, n. 1/2, p. 25, doi. 10.5489/cuaj.3315
    By:
    • Nayan, Madhur;
    • Bhlndi, Bimal;
    • Yu, Julie L.;
    • Muhammad Mamdani;
    • Fleshner, Neil E.;
    • Hermanns, Thomas;
    • Chung, Peter;
    • Milosevic, Michael;
    • Bristow, Robert;
    • Warde, Padraig;
    • Hamilton, Robert J.;
    • Finelli, Antonio;
    • Jewett, Michael A. S.;
    • Zlotta, Alexandre R.;
    • Sridhar, Srikala S.;
    • Kulkarni, Girish S.
    Publication type:
    Article
    36
    37

    Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.

    Published in:
    Canadian Urological Association Journal, 2014, v. 8, n. 11/12, p. 398, doi. 10.5489/cuaj.2426
    By:
    • Richter, Suzanne;
    • Jo-An Seah;
    • Pond, Gregory R.;
    • Gan, Hui K.;
    • Mackenzie, Mary J.;
    • Hotte, Sebastien J.;
    • Mukherjee, Som D.;
    • Murray, Nevin;
    • Kollmannsberger, Christian;
    • Heng, Daniel;
    • Haider, Masoom A.;
    • Halford, Robert;
    • Ivy, S. Percy;
    • Moore, Malcolm J.;
    • Sridhar, Srikala S.
    Publication type:
    Article
    38
    39

    Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process.

    Published in:
    Canadian Urological Association Journal, 2013, v. 7, n. 9/10, p. 312, doi. 10.5489/cuaj.1506
    By:
    • Seah, Jo-An;
    • Biais, Normand;
    • North, Scott;
    • Rahim, Yasmin;
    • Ruether, Dean;
    • Black, Peter C.;
    • Zlotta, Alexandre R.;
    • Wood, Lori;
    • Sridhar, Srikala S.
    Publication type:
    Article
    40
    41

    Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.

    Published in:
    World Journal of Urology, 2022, v. 40, n. 11, p. 2707, doi. 10.1007/s00345-022-04160-7
    By:
    • Einerhand, Sarah M. H.;
    • Black, Anna J.;
    • Zargar, Homayoun;
    • Fairey, Adrian S.;
    • Dinney, Colin P.;
    • Mir, Maria C.;
    • Krabbe, Laura-Maria;
    • Cookson, Michael S.;
    • Jacobson, Niels-Erik;
    • Montgomery, Jeffrey S.;
    • Vasdev, Nikhil;
    • Yu, Evan Y.;
    • Xylinas, Evanguelos;
    • Kassouf, Wassim;
    • Dall'Era, Marc A.;
    • Sridhar, Srikala S.;
    • McGrath, Jonathan S.;
    • Aning, Jonathan;
    • Shariat, Shahrokh F.;
    • Wright, Jonathan L.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Enfortumab Vedotin in urothelial cancer.

    Published in:
    Therapeutic Advances in Urology, 2020, v. 12, p. 1, doi. 10.1177/1756287220980192
    By:
    • Alt, Marie;
    • Stecca, Carlos;
    • Tobin, Swanee;
    • Jiang, Di Maria;
    • Sridhar, Srikala S.
    Publication type:
    Article
    50

    Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.

    Published in:
    2020
    By:
    • Hansen, Aaron R.;
    • Ala‐Leppilampi, Kari;
    • McKillop, Chris;
    • Siu, Lillian L.;
    • Bedard, Philippe L.;
    • Abdul Razak, Albiruni R.;
    • Spreafico, Anna;
    • Sridhar, Srikala S.;
    • Leighl, Natasha;
    • Butler, Marcus O.;
    • Hogg, David;
    • Sacher, Adrian;
    • Oza, Amit M.;
    • Al‐Agha, Rany;
    • Maurice, Catherine;
    • Chan, Christopher T.;
    • Shapera, Shane;
    • Feld, Jordan J.;
    • Nisenbaum, Rosane;
    • Webster, Kimberly
    Publication type:
    journal article